Le Lézard
Classified in: Health
Subject: SVY

$17.3 Bn Stem Cell Banking Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global stem cell banking market was worth US$ 8.1 Billion in 2018

Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow.

These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.

Looking forward, we expect the global stem cell banking market to reach a value of US$ 17.3 Billion by 2024, exhibiting a CAGR of 13.5% during 2019-2024.

Global Stem Cell Banking Market Drivers:

While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.

Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.

Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.

Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.

Product Type Insights:

On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.

Service Type Insights:

Based on service types, the market has been segmented as sample preservation and storage; sample analysis; sample processing; and sample collection and transportation.

Bank Type Insights:

Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.

Utilization Insights:

Based on the utilization, the market has been segregated as used and unused.

Application Insights:

On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.

Regional Insights:

On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:

The market is fragmented in nature with the presence various international as well as regional players. Some of the leading players operating in the market are:

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends

5 Global Stem Cell Banking Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Service Type
5.5 Market Breakup by Bank Type
5.6 Market Breakup by Utilization
5.7 Market Breakup by Application
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Product Type
6.1 Adult Stem Cells
6.2 Human Embryonic Cells
6.3 IPS Cells

7 Market Breakup by Service Type
7.1 Sample Preservation and Storage
7.2 Sample Analysis
7.3 Sample Processing
7.4 Sample Collection and Transportation

8 Market Breakup by Bank Type
8.1 Private
8.2 Public

9 Market Breakup by Utilization
9.1 Used
9.2 Unused

10 Market Breakup by Application
10.1 Personalized Banking Applications
10.2 Research Applications
10.3 Clinical Applications

11 Market Breakup by Region

12 Global Stem Cell Banking Industry: SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 CBR Systems Inc.
16.3.2 China Cord Blood Corporation
16.3.3 Cordlife
16.3.4 Cordvida
16.3.5 Cryo-Cell
16.3.6 Cryo-Save AG (A Group of Esperite)
16.3.7 Cryoviva India
16.3.8 Lifecell
16.3.9 Smart Cells International Ltd
16.3.10 Viacord

For more information about this report visit https://www.researchandmarkets.com/research/jb9sz4/17_3_bn_stem?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 03:01
Sirona Biochem Corp. is pleased to announce that the patent for TFC-1067 entitled "Gem Difluorocompounds as Depigmenting or Lightening Agents" was granted in the USA, as expected, and will be published in the official database in the coming month....

at 03:00
The Virginian, a large Continuing Care/Life Plan retirement community located in Fairfax, Virginia was recently acquired by an affiliate of Focus Healthcare Partners LLC (FHP). In connection with the acquisition, FHP retained Des Moines, Iowa based...

at 03:00
Dr. Bobbak "Bobby" Mansouri will begin treating patients at U.S. Dermatology Partners Tyler and Lindale June 17th. Dr. Mansouri is a board-certified dermatologist specializing in the diagnosis and treatment of disorders of the hair, skin, and nails....

at 03:00
NJ Top Dentists is proud to present Elizabeth Kilpatrick-Fox, DMD, DICOI for 2019. Conveniently located in Swedesboro, New Jersey, Dr. Elizabeth Kilpatrick-Fox provides residents of Gloucester county with her years of dental experience and...

at 03:00
New research1 released today, commissioned by pelvic health specialist INNOVO®, reveals the extent of the taboo surrounding bladder weakness, which affects 1 in 3 women in the UK2 and impacts millions of women's lives every day.  Just over 40 per...

at 02:30
Elthera is pleased to announce that it has been awarded 2.5 M ? through the Horizon 2020 programme. Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative, aimed at securing Europe's global...

News published on 22 march 2019 at 19:15 and distributed by: